glp-1 digestive blockage class action in michigan Ozempic Lawsuit & Gastroparesis GLP-1 Receptor Agonists in Gastrointestinal

Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal conditions like gastroparesis may rule out tirzepatide and similar GLP-1 based therapies

The approval was based on data from two randomized, double-blind, placebo-controlled studies involving more than 3,000 overweight or obese adults

Unlike traditional GLP-1 drugs, tirzepatide targets both GLP-1 and GIP receptors, unlocking superior weight-loss results compared to semaglutide (OZEMPIC, WEGOVY)

Twenty minutes later, I was horizontal on the couch, wondering if I'd ever want to look at food again

The first week, I didnt notice much and almost stopped